Previous 10 | Next 10 |
NovAccess Global (XSNX) announces that it has received a "productive response" from the U.S. FDA on its pre-investigational new drug ((IND)) meeting request regarding the development plan for Glioblastoma Multiforme ((GBM)) patients, including the clinical study design and dosing strategy for...
CLEVELAND, OH / ACCESSWIRE / June 29, 2021 / NovAccess Global Inc. (OTC PINK:XSNX) announced today that it received a productive response from the U.S. Food and Drug Administration (FDA) on its pre-investigational new drug (IND) meeting request regarding the development plan for Glioblastoma...
CLEVELAND, OH / ACCESSWIRE / June 8, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) (the 'Company' or 'NovAccess'), a cancer therapeutics company with operations in biotechnology, is pleased to announce that it has filed the Form 10-K annual filing for the fiscal year ending September 30, 202...
Provides advancement for its immunotherapy technology against brain tumors into human clinical trials CLEVELAND, OH / ACCESSWIRE / November 18, 2020 / NovAccess Global Inc. (OTC PINK:XSNX) (the "Company" or "NovAccess"), a cancer therapeutics company with operations in biotechnology is ...
NovAccess Global Enhances Scientific Advisory Board with Distinguished Industry Experts and adds Chief Financial Officer CLEVELAND, OH / ACCESSWIRE / October 21, 2020 / NovAccess Global Inc. (OTC PINK:XSNX) (the "Company" or "NovAccess"), a cancer therapeutics company with operations in...
Leadership by world-renown cancer researcher signals commitment to driving current and forthcoming biomedical opportunities CLEVELAND, OH / ACCESSWIRE / October 15, 2020 / NovAccess Global, Inc. (OTC PINK:XSNX), announced today the addition of published researcher, and patent author Dr....
Innovest Global Receives 7.5 Million Shares of NovAccess Global Common Stock as Consideration for StemVax Therapeutics; Divestiture of Biotech Subsidiary Signals Renewed Focus on Growing Industrials Business CLEVELAND, OH / ACCESSWIRE / September 10, 2020 / Innovest Global Inc. (OTC PIN...
Acquisition Launches NovAccess Shift, Focusing on Diagnostics and Therapeutics in Cancer CLEVELAND, OH / ACCESSWIRE / September 9, 2020 / NovAccess Global, Inc. (OTCPINK:XSNX), today announced that it has acquired 100% ownership of Pasadena-based StemVax Therapeutics from Innovest Glob...
StemVax Public Spinoff Complete Upon Completion of Reverse Stock Split; Transaction to Notably Strengthen Innovest Global Balance Sheet CLEVELAND, OH / ACCESSWIRE / August 11, 2020 / Innovest Global Inc. (OTCPINK:IVST), a diversified industrials company, today announced it has entered i...
PHOENIX, AZ / ACCESSWIRE / June 11, 2019 / The Stock Day Podcast welcomed XsunX, Inc. (OTC PINK: XSNX) ("The Company"), a company that specializes in the sale, design, and installation of solar photovoltaic power generation (PV), energy storage, and energy efficiency technologies to provide ...
News, Short Squeeze, Breakout and More Instantly...
CLEVELAND, OH / ACCESSWIRE / May 21, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a pioneering biomedical company developing innovative immunotherapies for brain tumor patients, today announced it has submitted a provisional patent for new intellectual property developed at Cedars-Sinai to advance...
CLEVELAND, OH / ACCESSWIRE / May 7, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the postponement of its Annual Meeting of Shareholder which was previously scheduled to be held in May 2024. The Company ...
CLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medi...